NCT00076674View on ClinicalTrials.gov

Levetiracetam Treatment of L-dopa Induced Dyskinesias

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

October 31, 2005

Conditions
DyskinesiasParkinson Disease
Interventions
DRUG

Intravenous Levodopa

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00076674 - Levetiracetam Treatment of L-dopa Induced Dyskinesias | Biotech Hunter | Biotech Hunter